APA (7th ed.) Citation

Abdallah, A., Mahmoudjafari, Z., Ahmed, N., Cui, W., Shune, L., McGuirk, J., . . . Atrash, S. (2023). Clinical efficacy of retreatment of daratumumab‐based therapy (D2) in daratumumab‐refractory multiple myeloma. European Journal of Haematology, 110(6), 626. https://doi.org/10.1111/ejh.13942

Chicago Style (17th ed.) Citation

Abdallah, Al‐Ola, et al. "Clinical Efficacy of Retreatment of Daratumumab‐based Therapy (D2) in Daratumumab‐refractory Multiple Myeloma." European Journal of Haematology 110, no. 6 (2023): 626. https://doi.org/10.1111/ejh.13942.

MLA (9th ed.) Citation

Abdallah, Al‐Ola, et al. "Clinical Efficacy of Retreatment of Daratumumab‐based Therapy (D2) in Daratumumab‐refractory Multiple Myeloma." European Journal of Haematology, vol. 110, no. 6, 2023, p. 626, https://doi.org/10.1111/ejh.13942.